PD-1 Inhibitor Clinical Trials in Chengdu, Sichuan
2 recruitingChengdu, Sichuan, China
Showing 1–2 of 2 trials
Recruiting
Phase 1
Safety and Efficacy of Whole Brain LDRT+ICI+Intrathecal Chemotherapy in Refractory Meningeal Metastasis of Lung Cancer
NSCLCLeptomeningeal MetastasisLow Dose Radiotherapy+1 more
Sichuan University10 enrolled1 locationNCT06431685
Recruiting
Phase 1
Safety and Tolerability of Low Dose Radiotherapy Concurrent SBRT and PD-1 Inhibitors in Advanced NSCLC.
NSCLCLow Dose RadiotherapyPD-1 Inhibitor+1 more
Sichuan University9 enrolled1 locationNCT05615142